Fox Chase Researcher Carolyn Fang Promoted to Associate Director for Population Science

Carolyn Y. Fang, PhD, professor and co-leader of the Cancer Prevention and Control Program.
Carolyn Y. Fang, PhD, professor and co-leader of the Cancer Prevention and Control Program.

PHILADELPHIA (October 23, 2020)— Carolyn Y. Fang, PhD, professor and co-leader of the Cancer Prevention and Control Program at Fox Chase Cancer Center, has been promoted to the role of associate director for Population Science.

“My goal is to expand the role and reach of population science research both regionally and nationally. We have an exceptional team of population scientists at Fox Chase Cancer Center who are experts across the cancer continuum, from prevention to survivorship” said Fang.

Fang’s new role will include overseeing the scientific and programming direction for population science at Fox Chase. Fang will be working closely with Susan G. Fisher, MS, PhD, who previously held the role, to develop initiatives that will support advances in population science research and strengthen interactions with community outreach and engagement.

Fisher currently serves as associate director for Cancer Health Disparities and Community Engagement. Additionally, she serves as chair and professor for the Department of Clinical Sciences at the Lewis Katz School of Medicine, Temple University.

Fang received her undergraduate degree in psychology from Colgate University in New York in 1991. She then went on to the University of California, Los Angeles, where she earned her master’s and doctorate in psychology. She has been part of Fox Chase since beginning her postdoctoral fellowship there.

Fang’s research focuses on understanding how behavioral, biological, and psychosocial factors may influence cancer risk, especially in Asian American populations. She has 20 years of experience in conducting both patient-focused and community-engaged research and is a national leader in the fields of biobehavioral oncology and cancer health disparities.

“I am honored to serve in this role and I am excited to work with Dr. Susan Fisher and the cancer center leadership to develop collaborative initiatives that leverage our strengths in population science to accelerate scientific discoveries that benefit the communities and populations in our catchment area and beyond,” said Fang. “I’m really delighted to be a part of these efforts.”

Fox Chase Cancer Center (Fox Chase), which includes the Institute for Cancer Research and the American Oncologic Hospital and is a part of Temple Health, is one of the leading comprehensive cancer centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase is also one of just 10 members of the Alliance of Dedicated Cancer Centers. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence six consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. It is the policy of Fox Chase Cancer Center that there shall be no exclusion from, or participation in, and no one denied the benefits of, the delivery of quality medical care on the basis of race, ethnicity, religion, sexual orientation, gender, gender identity/expression, disability, age, ancestry, color, national origin, physical ability, level of education, or source of payment.

For more information, call 888-369-2427